A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases

Abroad (travel likely)RecruitingPHASE1

Conditions

Systemic Lupus Erythematosus (SLE) · Lupus Nephritis (LN) · Sjogren's Syndrome (SS) · Inflammatory Myopathy · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis · Antiphospholipid Syndrome (APS)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Institute of Hematology & Blood Diseases Hospital, China, Tianjin, China
Contact: Study coordinator (Ying Wang) · wangying1@ihcams.ac.cn · 15900225626
Study coordinator · wangying1@ihcams.ac.cn

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease

Systemic Lupus Erythematosus · Systemic Sclerosis · Inflammatory Myopathy

Abroad (travel likely)Recruiting

Shanghai, China

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

Systemic Lupus Erythematosus · Inflammatory Myopathy · Systemic Sclerosis (SSc)

Abroad (travel likely)RecruitingPHASE2

Beijing, China

US Zamto-cel Autoimmune Diseases

Lupus Nephritis · Systemic Lupus Erythematosus · Systemic Sclerosis (SSc)

Abroad (travel likely)RecruitingPHASE1

Milwaukee, United States

Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases

Autoimmune Diseases · Systemic Lupus Erythematosus · Systemic Sclerosis

Abroad (travel likely)RecruitingEARLY_PHASE1

Shanghai, China